Approvals/NMPA/Mixed Protanine Zinc Recombinant Human Insulin Lispro Injection(25R)

Approved

生物制品

Mixed Protanine Zinc Recombinant Human Insulin Lispro Injection(25R)

Eli Lilly Nederland BV🇨🇳 National Medical Products Administration

Approval Id: 7MazXbC5CkK
Approval Number: S20170015
Generic Name: 精蛋白锌重组赖脯胰岛素混合注射液(25R)
Generic Name En: Mixed Protanine Zinc Recombinant Human Insulin Lispro Injection(25R)
Trade Name: 优泌乐25
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 3ml:300单位(笔芯)
Reg Date: 2019-08-08
Expired Date: 2024-08-07
Company Name: Eli Lilly Nederland BV
Company Address: Papendorpseweg 83,3528 BJ Utrecht,the Netherlands
Production Company Name: eli lilly italia s.p.a.
Production Company Address: Via Gramsci 731-733, Sesto Fiorentino, 50019, Italy
Company Detail Path: /organization/eli-lilly-nederland-bv

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Aug 8, 2019

Approval ID

7MazXbC5CkK

Type

生物制品